Scarica l'app Stockscreener
5.5595
2.68%
0.1395
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Compass Therapeutics stock rating reaffirmed at Citizens on trial progress By Investing.com - Investing.com Canada
What Compass Therapeutics (CMPX)'s Pipeline Progress And 2025 Losses Reveal About Its Oncology Strategy - Yahoo Finance
A Look At Compass Therapeutics (CMPX) Valuation After Recent Trial Milestones And FDA Clearance - Sahm
What is HC Wainwright's Estimate for CMPX Q1 Earnings? - MarketBeat
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
Jefferies raises Compass Therapeutics stock price target on trial progress By Investing.com - Investing.com Australia
Jefferies raises Compass Therapeutics stock price target on trial progress - Investing.com
Compass Therapeutics stock holds Outperform at William Blair ahead of trial data - Investing.com Canada
Raymond James reiterates Compass Therapeutics stock Outperform rating By Investing.com - Investing.com Canada
Raymond James reiterates Compass Therapeutics stock Outperform rating - Investing.com
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - Investing News Network
Compass Therapeutics (NASDAQ:CMPX) Releases Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Compass Therapeutics' Q4 Net Loss Narrows - marketscreener.com
Earnings Flash (CMPX) Compass Therapeutics Posts Q4 Net Loss $0.09 a Share, vs. FactSet Est of $0.09 Loss - marketscreener.com
Compass Therapeutics' 2025 net loss widens as R&D costs jump - TradingView
Compass Therapeutics 10-K: $0.0M Revenue, $(0.42) EPS on $(66.5)M Net Loss - TradingView
Cancer trial hits survival milestone as Compass funds work to 2028 - Stock Titan
How Palo Alto’s New Stake and Rising Institutional Ownership At Compass Therapeutics (CMPX) Has Changed Its Investment Story - simplywall.st
Assessing Compass Therapeutics (CMPX) Valuation As CTX-009 Gains Attention In Biliary Tract Cancer Market - Yahoo Finance
Monashee Investment Management Boosts Stake in Compass Therapeutics - National Today
Signal Recap: Does Compass Therapeutics Inc have a competitive edgeQuarterly Performance Summary & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Monashee Investment Management LLC Has $4.38 Million Stake in Compass Therapeutics, Inc. $CMPX - MarketBeat
Compass Therapeutics, Inc. (CMPX) Stock Analysis: Exploring a 130% Potential Upside in Biotech - DirectorsTalk Interviews
Compass Therapeutics earnings on deck as pivotal cancer data looms By Investing.com - Investing.com Canada
Compass Therapeutics earnings on deck as pivotal cancer data looms - Investing.com
Compass Therapeutics Inc. expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Zacks.com Spotlights Orla Mining, FIGS, and Compass Therapeutics - Intellectia AI
Is Compass Therapeutics Inc. stock forming a cup and handleJuly 2025 Retail & Reliable Entry Point Trade Alerts - mfd.ru
Compass Therapeutics Moves CTX-10726 Into the Clinic: What Early Investors Should Know - TipRanks
Compass Therapeutics (CMPX) to Release Quarterly Earnings on Thursday - MarketBeat
Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Support Test: Can Compass Therapeutics Inc. sustain its profitabilityOil Prices & Weekly Return Optimization Alerts - mfd.ru
Bearish Setup: Will Compass Therapeutics Inc stock go up in YEAREarnings Miss & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Compass Therapeutics (NASDAQ:CMPX) Raised to "Hold" at Wall Street Zen - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Research Coverage Started at Craig Hallum - Defense World
Compass Therapeutics (NASDAQ:CMPX) Raised to “Hold” at Wall Street Zen - Defense World
How much upside does Compass Therapeutics Inc. haveWall Street Watch & Daily Stock Momentum Reports - mfd.ru
Craig-Hallum initiates coverage on Compass Therapeutics stock with Buy rating - Investing.com Canada
Compass Therapeutics stock rises after Craig-Hallum initiates coverage with Buy - Investing.com Canada
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Craig Hallum - MarketBeat
Compass Therapeutics, Inc. (CMPX) Stock Analysis: A Biotech With 109% Potential Upside - DirectorsTalk Interviews
Will Compass Therapeutics Inc. outperform during market ralliesJuly 2025 Institutional & Entry Point Confirmation Signals - mfd.ru
Compass Therapeutics (NASDAQ:CMPX) Cut to "Sell" at Wall Street Zen - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Cut to “Sell” at Wall Street Zen - Defense World
Compass Therapeutics, Inc. (CMPX) Stock Analysis: Evaluating the 112.66% Potential Upside - DirectorsTalk Interviews
Canaccord Genuity raises Compass Therapeutics stock price target on Phase 2/3 data expectations - Investing.com Canada
Compass Therapeutics (NASDAQ:CMPX) Sets New 1-Year HighHere's What Happened - MarketBeat
Compass Therapeutics stock hits 52-week high at 6.51 USD By Investing.com - Investing.com Nigeria
0.44%
20.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):